CONFIRMED PARTICIPANTS

   Dr. Roy Goodacre

President of the Metabolomics Society [MetSoc]; The University of Liverpool, UK

Trained as a microbiologist and analytical chemist, Roy’s research develops metabolomics and spectroscopy to address interesting biological questions. He has helped establish mass spectrometry-based metabolomics for long-term studies and is employing these methods for clinical/health and plant studies, as well as for understanding microbial systems. He has developed a variety of different Raman spectroscopy approaches for bioanalysis with a particular focus on metabolite quantification and image analysis of single cells.

Roy helped establish the Metabolomics Society and is currently its President, and is Editor-in-Chief of the journal Metabolomics.

   Dr. Leo Cheng

Harvard Medical School, USA

Leo Cheng was born in Shanghai, China, and earned his Master of Science from Nanjing University, China, in 1985. After moving to the U.S. in 1986, he went on to earn his PhD in 1993 from Brandeis University with Professor Judith Herzfeld and Professor Robert G. Griffin at MIT on solid state proton NMR. He has been at Massachusetts General Hospital and Harvard Medical School since 1994, first as a postdoctoral fellow, where he discovered intact tissue high-resolution magic angle spinning (HRMAS) NMR, and then as faculty, where he further developed NMR-based metabolomics for human diseases including cancers and neurological disorders. Since 2003, he has served on numerous American and international committees for scientific grant reviews, including multiple chartered memberships on NIH study sections. He has served as a member of the Editorial Advisory Board for NMR in Biomedicine and other journals since 2005. Currently, he serves multiple leading roles in metabolomics and metabolomic imaging with various international organizations, including the Chair of the NMR Technology Task Group and the Secretary for the Metabolomics Quality Assurance & Quality Control (mQACC); the Chair-Elect of the NMR Interest Group and the Founding Chair of the Spatial Metabolomics/Lipidomics Interest Group for the Metabolomics Association of North America (MANA); the Founding Chair of the Metabolomics and Metabolomic Imaging (MMI) Study Group for the International Society of Magnetic Resonance in Medicine; and the Co-Program Chair of the WMIC 2024 for the World Molecular Imaging Society.

     Dr. Arthur S. Edison

University of Georgia, USA

Art Edison is a Georgia Research Alliance Eminent Scholar and Professor of Biochemistry & Molecular Biology. He is a member of the Complex Carbohydrate Research Center (CCRC) and Institute of Bioinformatics at the University of Georgia. His undergraduate degree was in Chemistry from the University of Utah where he worked with David Grant and Bill Epstein to use NMR to characterize monoterpenes from sagebrush. He received his Ph.D. in biophysics from the University of Wisconsin-Madison, where he developed and applied NMR experimental and theoretical methods for protein structural studies under the supervision of John Markley and Frank Weinhold. He was a Jane Coffin Childs postdoctoral fellow with Tony Stretton at UW-Madison and studied neuropeptides in the parasitic nematode Ascaris suum. He joined the faculty at the University of Florida and the National High Magnetic Field Laboratory in 1996. He advanced from Assistant to Full Professor in the UF Department of Biochemistry & Molecular Biology. Prof. Edison was the founding PI and Director of the NIH-funded Southeast Center for Integrated Metabolomics, and his research focuses on the role of small molecules in biology and disease. In 2015, Edison moved to the University of Georgia where he directs the CCRC NMR facility, which supports research in both metabolomics and structural biology. Edison’s research group collaborates on several metabolomics projects from microbes to humans. Most recently, Prof. Edison and colleagues at the University of Connecticut and the University of Wisconsin-Madison have been funded by the NSF to establish the Network for Advanced NMR (NAN) to improve access to NMR resources for non-NMR experts. NAN will include ultra-high field 1.1 GHz NMR instruments at both UGA and UW-Madison and networked data portal and infrastructure through UConn.

   Dr. Facundo Fernández

Georgia Institute of Technology, Gerogia, USA

Prof. Facundo M. Fernández is the Regents’ Professor and Vasser-Woolley Chair in Bioanalytical Chemistry in the School of Chemistry and Biochemistry at the Georgia Institute of Technology. He received his BSc and MSc in Chemistry from the Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires in 1995, and his PhD in Analytical Chemistry from the same University, in 1999.  Between 2000 and 2001, he was a postdoc in the research group of Richard N. Zare in the Department of Chemistry at Stanford University.  Between 2002-2003, he joined the group of Vicki Wysocki in the Department of Chemistry at the University of Arizona as a senior postdoc and then research scientist. Prof. Fernandez is internationally renowned for his work in bioanalytical chemistry, with his research focusing on the development of new tools for assaying small volume samples, tissues, and single cells, and applying such methods to better understanding diseases such as cancer, CF and IBD. He is the author of 220+ peer-reviewed publications, has presented 200+ invited lectures, and graduated 29 Ph.D. and M.Sc. students. He is also the academic director for the Systems Mass Spectrometry Core (SyMS-C) at the Parker H. Petit Institute for Bioengineering and Bioscience at Georgia Tech, where he oversees a portfolio numerous mass spectrometers from most major vendors.  He has received several awards, including the NSF CAREER award, the CETL/BP Teaching award, the Ron A. Hites best paper award from the American Society for Mass Spectrometry, and the Beynon award from Rapid Communications in Mass Spectrometry, among others. He serves on the editorial board of The Analyst and as an Associate editor for the Journal of the American Society for Mass Spectrometry and Frontiers in Chemistry. His current research team of 15-20 people is interested in metabolomics, development of new ionization sources, MS imaging, machine learning and ion mobility spectrometry. The research is supported by agencies such as NIH, NSF, NASA, IARPA and DoD. In his free time, he enjoys camping and off-roading with his family, kayaking, and climbing summits to connect with other nerdy people using a tiny ham radio.

   Dr. Pablo A. Hoijemberg

Centro de Investigaciones en Bionanociencias (CIBION-CONICET), Buenos Aires, Argentina

He obtained his titles of Licenciado in Chemical Sciences and PhD in Chemistry from the Facultad de Ciencias Exactas y Naturales at the Universidad de Buenos Aires (Argentina). He's conducted research in the field of Photochemistry, before switching to NMR based Metabolomics. He began working as a Postdoctoral Researcher with Dr. István Pelczer, at the Department of Chemistry at Princeton University, where he conducted research on NMR metabolomics on biological samples, as well as chemometric analysis of complex mixtures. Then he joined the "Centro de Investigaciones en Bionanociencias (CIBION-CONICET)", Center for Bionanosciences Research, in Buenos Aires, Argentina, leading the Bioanalytical NMR Group and securing funding for the creation of the NMR Laboratory. He finally established the NMR Lab with a 500 MHz Bruker Avance Neo NMR spectrometer, having the first HR-MAS probe to have been installed in Argentina. He is one of the LAMPS founding members and an active member of the community. He co-organized the 2018 Argentina Magnetic Resonance Workshop and he's involved in the organization of the current LAMPS symposium. He was Guest Editor of the Research Topic at Frontiers in Molecular Biosciences for the IV LAMPS Symposium, and he'll continue as such for the Research Topic to be launched for this edition as well. His group focused on the improvement of data analysis on NMR based metabolomics, with emphasis on the use of 2D 1H JRES spectra. His group has developed COCOA-POD, a tool that overcomes peak overlap in 1D 1H spectral sets by using statistical total correlation (STOCSY) on the nontilted 2D JRES spectra and projecting the outcome on f2 to yield "overlap-free pseudospectra” ready for 1H 1D queries. Later on they developed CSMDB, a multiplet database with its own built-in search engine based on matching both pJRES peaks and the multiplet profiles, for improved matching confidence levels. Lately, they've completed MAPA, a tool generated for peak alignment among spectra, based on multiplet matching and building of correspondence table, for the creation of tabulated data or reconstructed spectra ready for statistical analysis. He began applying these tools on NMR metabolomics studies on cancer.  His current research interests expand with the optimization of metabolite production with in vitro plant cultivation using experimental design methodologies. More ideas are in the works to continue also on the path of development of data analysis tools.

   Dr. José Luis Izquierdo-García

Universidad Complutense de Madrid, Madrid, Spain

Over the past decade, Jose Izquierdo has focused on studying metabolic alterations linked to disease development. Trained in physics, he specialized in NMR-based metabolomic analysis during his doctoral studies. A NIH USA fellowship facilitated his postdoctoral research at the University of California San Francisco (UCSF), where he developed a hyperpolarized MRI protocol for glioblastomas with IDH1 mutation. Upon returning to Spain in 2015 through a Marie Curie Incoming fellowship, Dr. Izquierdo joined Spanish Cardiovascular Research Centre (CNIC) to establish a clinical metabolomics line focusing on cardio-respiratory conditions. This laid the foundation for his current research on diagnosing and prognosing respiratory infections through NMR-based metabolomic analysis. In 2018 Dr. Izquierdo joined CIC biomaGUNE as a senior researcher to lead the metabolomics line. Realizing the practical challenges of implementing their research in hospitals due to the high cost and helium dependency of NMR equipment, they explored alternatives with benchtop NMR devices using permanent magnets. Collaborating with MAGRITEK, a leading manufacturer in this field, they validated metabolic biomarkers for tuberculosis detection through bNMR, becoming pioneers in bNMR-based metabolomics. In December 2020, Izquierdo joined UCM as the PI of the "NMR and Imaging in Biomedicine" group. Ongoing research focuses on further developing bNMR-based clinical metabolomics by validating it in clinical studies of different diseases, monitoring individuals at risk for early markers, and advancing the necessary technological development to enhance bNMR capabilities. As the group's PI, he secured funding for equipment acquisition, notably a Magritek 80MHz bNMR spectrometer. His dedication is to ensure that his scientific progress positively impacts society, particularly through the clinical application of research. Within the CIBERES network, he closely collaborates with medical professionals to address their needs. Besides CIBERES, he engages with European networks like INNOVA4TB and ADVANCETB, as well as collaborating with international groups from Uruguay, USA, and UK. Connections with patient associations are also maintained.  Furthermore, he participated in the European Metabolomics Experts Committee to decide the future of "Metabolomics User Case" in the European Bioinformatics Platform ELIXIR (25/04/2017).

   Dr. Julia Kuligowski

Instituto La Fe, Valencia, Spain

Julia Kuligowski is a Principal Investigator at the Neonatal Research Group at the Health Research Institute La Fe in Valencia (Spain). Her research interests focus on the detection of molecular biomarkers in biofluids of newborns with different pathologies, including hypoxic-ischemic encephalopathy and severe hypoxia secondary to persistent pulmonary hypertension. She has been working in the area of development and validation of oxidative/nitrosative stress biomarkers and tested their applicability for elucidating the biochemical and clinical effects of hypo- and hyperoxia and their relevance for the development of oxidative-stress related pathologies in preterm infants. More recently, she got involved in the development of personalized nutrition approaches for the preterm infant. She has been evaluating the impact of maternal diet on the composition of human milk and how the different compounds present in milk affect growth, health, and development of the preterm infant and she has been working on the characterization of human milk extracellular vesicles, with special emphasis on their lipidic make-up, and how the properties of those vesicles could be exploited for disease prevention or treatment of preterm infants. She is actively participating in different scientific societies and international working groups including the  Metabolomics Quality Assurance and Quality Control Consortium (since 2019), the International Society for Extacellular Vesicles (ISEV) – Milk Task Force, Rigor and Standardization Subcommittee (since 2022), the Metabolomics Society (EEUU) – Lipidomics Task Group (since 2023) and International Organizing Committee (Metabolomics 2019 and 2022), and she acts as Short Term Scientific Mission Coordinator of the COST action EpiLipidNet (2021-2024). Results of her work have resulted in over 140 publications in peer-reviewed, scientific journals and she participated in dissemination and public outreach activities to promote breastfeeding and natural lactation as well as interactive science workshops for kids.

   Dr. Ewy Mathé

National Centre for Advancing Translational Sciences, Bethesda, MD, USA

Dr. Ewy Mathé is the Director of Informatics in the Division of Preclinical Innovation at NCATS. She received a Bachelor’s degree in Biochemistry (minor in Sociology) from Mount Saint Mary’s University, MD in 2000 and a PhD in Bioinformatics from George Mason University, VA in 2006. During her post-doctoral training with Dr. Curtis Harris (NCI/NIH), she discovered putative esophageal and lung cancer biomarkers using miRNA microarrays and metabolomics, leading to two patent applications. She then joined Dr. Rafael Casellas’ laboratory (NIAMS/NIH), where she aimed to better understand modalities of transcriptional regulation in B lymphocytes, using next-generation sequencing techniques. Since then, she has focused on developing methods and frameworks to guide analysis, integration, and interpretation of high-throughput sequencing and multi-omic data to uncover biological mechanisms and identify valid biomarkers and therapeutic targets for the diagnosis, prognosis, and treatment of various diseases.  She is very active in the metabolomics community (Metabolomics of North America, Metabolomics Society, Consortium of Metabolomics Studies) and is a proponent of open-source software development and data.  As Director of Informatics, she leads a diverse team of experts in bioinformatics, cheminformatics, data science, and software development that empower translational scientists to make meaningful data-driven decisions in their research. Her team’s mission is to derive actionable insights from translational research data by developing computational resources, methods and tools, including AI/ML.  To this end, the group optimizes the use of large scale molecular (high throughput screening, multi-omics, etc.) and knowledge-driven datasets (various sources of information on drugs, including mechanisms of action, regulatory status, etc., drug targets, diseases, biological functions, etc).  

   Dr. Norberto Peporine Lopes

Faculdade de Ciências Farmacêuticas de Ribeirão Preto - FCFRP-Universidade de São Paulo, Ribeirão Preto, Brazil.

Norberto Peporine Lopes is a Pharmacist, Master of Pharmaceutical Sciences, Doctor in Chemistry from USP, and a Full Member of the Brazilian Academy of Sciences. He currently holds the position of Full Professor at FCFRP-USP, coordinator of the Research Center for Natural and Synthetic Products, and the Central Mass Spectrometry of Organic Micromolecules. In his unit, he has held various elective positions, notably the Head of the Department of Physics and Chemistry and the President of the Research Committee. He was a member of the USP Advanced Study Group at the Ribeirão Preto Campus and the Management Committee of the Supera Parque Technology Park. He currently serves as the Coordinator of the Ribeirão Preto Pole of INOVA-USP (University of São Paulo's Innovation Center) and coordinator of NIDUS (Center for Company and Entrepreneur Formation), the country's first Innovation Residency. He is an associate member of the Brazilian Society of Pharmaceutical Sciences, the Mass Spectrometry Society (BrMass), the Brazilian Chemical Society (SBQ), and the Brazilian Society of Pharmacognosy. He is also a member of the American Chemical Society, the Society for Medicinal Plant and Natural Product Research (GA), and a Fellow of the Royal Society of Chemistry. He has held elective positions in the SBQ, including President, President-elect, Advisory Council Member, Fiscal Council Member and President, General Secretary, Treasurer, Vice-Director, and Treasurer of the Natural Products Division. At BrMAss, he served as Financial Director and Advisory Council Member. He has completed short-term internships in Germany (University of Tübingen), the United States of America (Washington State University), and the United Kingdom (University of Bristol). He developed his postdoctoral research in Mass Spectrometry of Natural Products at the University of Cambridge (UK) and served as a Visiting Professor in Mass Spectrometry at the University of Muenster. He has published more than 500 scientific articles (IH = 49) and received 10 awards, notably the BrMASS Medal, the SBQ Fernando Galembeck Innovation Award, and the Jeremy Knowles Award from the Royal Society of Chemistry. He is currently Editor of Rapid Communication in Mass Spectrometry (Wiley), Planta Medica (GA), Scientific Reports (Nature Publishing Group), OMEGA-ACS (American Chemical Society), and Chemical Society Reviews. He works in the fields of Natural Product Chemistry and Mass Spectrometry, with an emphasis on Chemical Ecology.

   Dr. Alan Cesar Pilon

Instituto de Química - Universidade Estadual Paulista "Júlio de Mesquita Filho" - IQ-UNESP, Araraquara, Brazil.

Alan C. Pilon is a chemist and an Assistant Professor in the Department of Biochemistry and Organic Chemistry at the Institute of Chemistry, São Paulo State University (IQ-UNESP-CAr). In 2015, he obtained his Ph.D. under Prof. Ian Castro-Gamboa supervision in Organic Chemistry and Natural Products from IQ-UNESP. His research journey took him abroad as a visiting researcher in Lloyd Sumer's lab at the Samuel Roberts Noble Foundation, Ardmore, USA (2013-2014), focusing on plant metabolomics. He also spent time at Leiden University (2013) alongside Prof. Young Hae Choi, employing computational tools in plant metabolomics. Post-Ph.D., Alan contributed to the development of the Natural Products database (NuBBE-DB) at IQ-UNESP (2015-2016) with Prof. Vanderlan da Silva Bolzani. His postdoctoral research at the School of Pharmaceutical Sciences, under the supervision of Prof. Norberto Peporine Lopes at the University of São Paulo (FCFRP-USP), explored Ecometabolomics in both degraded and preserved areas of the Atlantic Forest (2016-2020). Further enhancing his international experience, he was a visiting researcher at Imperial College London, Ascot, England (2019-2020), in Jon Lloyd's group, studying the evolution of secondary metabolism in angiosperms. Back in Brazil, his postdoctoral work at UNB/FCFRP-USP (2020-2022) focused on metabolomic and larvicidal studies of Atlantic Forest species against Aedes aegypti. Additionally, Alan contributed to the startup Lychnoflora, managing project workflows and process mapping. Currently, he boasts 37 publications, 3 editorials, 5 book chapters, and 10 awards, notably the Young Investigator in Plant Metabolomics at the International Congress of the Metabolomics Society in Washington, USA, 2012. His work emphasizes the chemistry of natural products from Brazilian biodiversity, focusing on ecometabolomics, analytical and computational tool development for compound elucidation, mass spectrometry, nuclear magnetic resonance, chemical ecology, and natural product libraries. He volunteered as a scientific disseminator (JP-Conecta and SBQ Bulletin) for the Young Researchers of the Brazilian Chemical Society (JP-SBQ 2019-2022) and co-founded the "Rede Metabolômica" community, an international group for discussion, sharing, and mobilization in Metabolomics. Recently he has been appointed as SBQ Paulista Regional Secretary and is an active LAMPS member.

   Dr. Oscar Millet

CIC bioGUNE, Bizkaia, Spain

Prof. Millet obtained a Degree in Chemistry (Univ. Ramon Llull, 1994) and Chemical Engineering (IQS, 1995). After obtaining a Ph D in Organic Chemistry (University of Barcelona, 1999) I joined the group of Lewis Kay in Toronto for a post-doctoral stay (University of Toronto, 2000-2004). I was then recipient of a Ramon y Cajal reincorporation contract at the Parc Científic de Barcelona (2004-2006) and I currently am a group leader at the Structural Biology Unit of the CIC bioGUNE. My research line focuses on the use of nuclear magnetic resonance (NMR) to the study of biologically relevant proteins and enzymes, paying special attention to the delicate balance existing between protein stability and dynamics. Such knowledge is applied for the development of new compounds with therapeutic activity in the field of rare diseases, and it has developed into the creation of a spin-off company, ATLAS Molecular Pharma. I have found a new pharmacological chaperone for the treatment of congenital erythropoietic porphyria, which is a repurposed drug and it has obtained the Orphan Drug Designation status. Additionally, I am also interested in the NMR-based metabolomics of biofluids for the diagnose of rare and prevalent diseases. I have been awarded the prize of the Real Sociedad Española de Química (2004), the Spanish NMR group prize (2005), the Elhuyar-Goldshmidt Prize (2022) and nominated Academic of the Academy of Medical Sciences of the Basque Country (2016). I am currently the president of the Spanish Chemical Biology group. 

   Dr. Cecilia Queijo

Laboratorio de Pesquisa Neonatal, Banco de Prevision Social, Montevideo, Uruguay

Cecilia Queijo is a prominent figure in the field of biochemistry in Uruguay. She serves as the Manager of the Reference Laboratory for Neonatal Screening at the Banco de Previsión Social (BPS) in Uruguay. Her work focuses on neonatal screening, which is crucial for early detection and treatment of congenital disorders. Queijo has held significant roles in various professional organizations. She is a former secretary of both the Latin American Confederation of Clinical Biochemistry (COLABIOCLI) and the Uruguayan Biochemical Association (ABU). Additionally, she has been recognized for her contributions to the field, including receiving the prestigious Reina Sofía Award in 2010 for her work in neonatal screening. Her involvement extends to international committees, such as the Task Force for Global Newborn Screening under the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), demonstrating her influence and commitment to advancing biochemical sciences on a global scale​ 

   Dr. Dajana Vuckovic

Concordia University, Montréal, Canada

Dajana Vuckovic (Hon. B.Sc. Chemistry, University of Toronto; Ph.D. Analytical Chemistry, University of Waterloo; PDF Chemical and Quantitative Proteomics, University of Toronto) is an Associate Professor and Concordia University Research Chair in Clinical Metabolomics and Biomarkers in the Department of Chemistry and Biochemistry at Concordia University. She is also the Director of Concordia’s Centre for Biological Applications of Mass Spectrometry and is a Concordia node leader of The Metabolomics Innovation Centre (TMIC), Canada’s national metabolomics network. The Vuckovic group develops new analytical methods and devices to improve metabolite coverage and data quality in metabolomics, with primary focus on low-abundance and unstable metabolites. Her current research interests include in vivo solid-phase microextraction, and the development and  implementation of less invasive microsampling approaches in clinical and pre-clinical research, with the over-reaching goal to facilitate biomarker discovery and validation in cardiovascular disease and nutritional lipidomics. She is co-author of more than 50 publications to date, and has given 55 invited talks and seminars. Her research program has been recognized by the 2023 Fred Beamish Award by the Canadian Society for Chemistry and 2019 Young Investigator Award by the Canadian Society of Mass Spectrometry. Dajana is an active member of metabolomics community and served as the scientific co-chair of Metabolomics 2023 conference held in Niagara Falls, Canada. She currently serves on the editorial boards of Bioanalysis and Analytical and Bioanalytical Chemistry, as Secretary for Metabolomics Association of North America (MANA) and is the co-Chair of the Best Practices Working Group of the international Metabolomics Quality Assurance and Quality Control Consortium (mQACC), whose objective is to harmonize and disseminate best QA/QC practices for untargeted metabolomics. 

   Dr. Tomáš Pluskal 

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czechia

Tomáš Pluskal is a researcher in the field of metabolomics, systems biology, and computational biology. He has made significant contributions to understanding the complex interactions within biological systems through advanced analytical techniques and computational tools. He is best known for his work in developing open-source tools and software for metabolomics research. One of his most notable contributions is the development of the mzmine software, a widely used platform for mass spectrometry data processing. This tool has been instrumental in advancing research in metabolomics by providing researchers with robust methods for data processing and analysis. After his Ph.D. research at Okinawa Institute of Science and Technology (OIST), Tomáš joined the Whitehead Institute in Cambridge, MA, where he continued his research in plant specialized metabolism. Currently, his lab at IOCB Prague is developing new computational and experimental workflows to understand and harness the full potential of plant specialized metabolism for the benefit of human health.

   Dr. María Eugenia Monge

Centro de Investigaciones en Bionanociencias (CIBION), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina

Independent Researcher of the National Scientific and Technical Research Council of Argentina (CONICET) and works at the Centro de Investigaciones en Bionanociencias (CIBION). In 2006, she obtained her Ph.D. in analytical and physical chemistry from the University of Buenos Aires. Between 2007 and 2014, she held postdoctoral positions in Italy, France, and the USA. In 2014, she was recruited by CONICET to set up a new laboratory in a new research center in Argentina, where she leads the Bioanalytical Mass Spectrometry Group and the Mass Spectrometry facility. Her research group develops MS-based metabolomics and lipidomics analytical methods with applications in health and the environment. As well, her group has contributed with pipelines for preprocessing LC-MS data for quality control procedures in untargeted workflows. She is co-author of >45 peer-reviewed publications. Since 2014, she has coordinated hands-on metabolomics courses at CIBION for South American students, and has participated in strengthening the Latin American community through teaching in Brazil, Colombia, Mexico, and Argentina. Since 2021, she is a founding member of LAMPS (Latin American Metabolic Profiling Society), and has contributed to engage LAMPS as an international affiliate of the Metabolomics Society. Since 2019, she has been a member of the metabolomics quality assurance and quality control consortium (mQACC), and she has been a member of the Metabolomics Society, where she serves on the Membership Committee. In 2022, she was elected to the Metabolomics Society Board of Directors. She is the vice-president of the Argentinean Mass Spectrometry Society. She has served as guest editor for the journal Metabolites, and is an editorial board member of GigaByte. In 2022, she was awarded the Metabolomics Society Medal.

   Dr. Matej Orešič

School of Medical Sciences, Örebro University, Örebro, Sweden

He holds a PhD in biophysics from Cornell University (1999; Ithaca, NY, USA). He is professor of medicine, with specialization in systems medicine at Örebro University (Sweden) and professor of biochemistry (metabolomics) at the University of Turku (Finland). Prof. Orešič’s main research areas include exposomics and metabolomics applications in biomedical research and systems medicine. He is particularly interested in the identification of environmental exposures (exposome) and disease processes associated with different metabolic phenotypes and the underlying mechanisms linking these processes with the development of specific disorders or their co-morbidities. Prof. Orešič also initiated the popular MZmine open-source project, which led to the development and release of popular software for metabolomics data processing. As of 2016, he was made a Lifetime Honorary Fellow of the Metabolomics Society. Prof.  Orešič currently serves as member of the Board of Directors of the Metabolomics Society and is one of the founders of the Nordic Metabolomics Society, previously serving as its chair of the board. In 2019, he co-chaired the 1st Gordon Research Conference on ‘Metabolomics and Human Health’ (Ventura, CA, USA). Previously, he also chaired the Keystone Symposium on Systems Biology of Lipid Metabolism (2015; Breckenridge, CO, USA).

   Dr. Tuulia Hyötyläinen

School of Science and Technology, Örebro University, Örebro, Sweden

She started her tenure as a professor of chemistry at Örebro University in 2016. Holding a Ph.D. in analytical chemistry from the University of Helsinki, Finland, her primary research interests lie in metabolomics and environmental studies. In the realm of metabolomics research, Tuulia's focus is on conducting comprehensive analyses of all metabolites within a studied biological system. This approach aims to unveil metabolic changes triggered by factors such as disease, environmental influences, nutrition, or genetic factors in an organism. Throughout her research, Tuulia has dedicated efforts to developing efficient, high-throughput methodologies for profiling biological samples. These methodologies encompass both traditional chromatographic methods and cutting-edge techniques, including comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry and ultra-high-performance liquid chromatography combined with various mass spectrometers. In her work, Tuulia has pioneered the development of non-targeted profiling methods for discovery studies and targeted analysis of specific compounds. The overarching objective is to achieve the most comprehensive coverage of the metabolome possible. The key focus is on enhancing the reliability and sensitivity of methodologies, particularly for the comprehensive profiling of complex samples. One of the primary challenges in her research involves identifying unknown compounds using mass spectrometric tools, leading to the development of software tools for the treatment of mass spectrometry data. Her current primary research areas include diabetes, fatty liver disease, traumatic brain injury, and exposome studies. Her research has successfully identified specific biomarkers that facilitate the diagnosis or early prediction of diseases. Furthermore, her goal is to pinpoint the metabolic pathways responsible for metabolic alterations in specific diseases or due to various challenges, such as environmental exposure to toxic substances or different nutritional interventions.

   Dr. Gonzalo Hernández Dossi

Laboratorio de Resonancia Magnética Nuclear, Departamento de Química Orgánica, Facultad de Química, Universidad de la República, Montevideo, Uruguay

He is an Assistant Professor in the Department of Organic Chemistry at Universidad de la República in Montevideo, Uruguay. His research interests lie in the application of nuclear magnetic resonance in the areas of medicinal chemistry and natural products research. Before getting into full time academic work he held positions in the pharmaceutical industry, both at large corporations and small startups. He holds a masters in Chemistry from Universidad de la República in Montevideo, Uruguay, and a PhD in Chemistry from Boston University in Boston, MA.

   Dr. Tito Damiani

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czechia

Tito Damiani is a researcher in the field of plant metabolomics and bioinformatics. After his PhD at the University of Parma, he joined the lab of Tomas Pluskal at IOCB Prague, where he contributed to the development of popular computational metabolomics tools such as the mzmine software and the mass spectrometry query language (MassQL). His current research focuses on multi-omics data integration (metabolomics and transcriptomics in particular) for the elucidation of the biosynthetic origin of specialised metabolites in non-model plant species.